Liver Disease Innovators
• Biotech
Jobs from the company:
Page 1 / 2
Next
Alentis Therapeutics
21-100
FTE
Alentis Therapeutics specializes in the discovery and development of groundbreaking therapies aimed at treating advanced liver diseases. With a strong focus on biotechnology, the company is at the forefront of innovation in the health sector, leveraging cutting-edge science to improve patient outcomes.
Funding
€167M
HQ City
Allschwil
Revenue Model
B2B
Employee Count
21-100
Last Funding Round
04/2023
Stage
Late
Team Growth
236%
YoY Website Traffic Growth
16%